THE SIGNIFICANCE AND DETERMINANTS OF DRUG METABOLISM IN MANSTEVENSON IH.1973; DIGESTION; SWITZ.; DA. 1973; VOL. 8; NO 1; PP. 80-86; BIBL. 1P.Serial Issue

THE BIOTRANSFORMATION OF CYCLOPHOSPHAMIDE IN MAN. ANALYSIS OF THE VARIATION IN NORMAL SUBJECTSMOURIDSEN HT; FABER O; SKOVSTED L et al.1974; ACTA PHARMACOL. TOXICOL.; DANEM.; DA. 1974; VOL. 35; NO 2; PP. 98-106; BIBL. 1P.1/2Article

INTERPATIENT VARIATION AND SIGNIFICANCE OF PLASMA LEVELS OF CHLORPROMAZINE IN PSYCHOTIC PATIENTSMARCH JE; DONATO D; TURANO P et al.1972; J. MED. EXPER. CLIN.; SWITZ.; DA. 1972; VOL. 3; NO 3; PP. 146-162; BIBL. 1P.Serial Issue

BIOAVAILABILITY OF DRUGS.JONES JC.1975; ROCKY MOUNTAIN MED. J.; U.S.A.; DA. 1975; VOL. 72; NO 7; PP. 285-288; BIBL. 4 REF.Article

MEASUREMENT OF VARIATION OF DRUG RESPONSES: SEQUENTIAL ANALYSIS OF QUANTAL SENSITIVITY DATA = MESURE DE LA VARIATION DE LA REPONSE AUX MEDICAMENTS: ANALYSE SEQUENTIELLE DES DONNEES QUANTIQUES SUR LA SENSIBILITEMCCAWLEY EL; WAYSON KA.1974; PHYSIOL. CHEM. PHYS.; U.S.A.; DA. 1974; VOL. 6; NO 3; PP. 275-282; BIBL. 6REF.Article

ENZYME INDUCTIONDOLLERY CT.1972; BRIT. J. ANAESTH.; G.B.; DA. 1972; VOL. 44; NO 9; PP. 961-966; BIBL. 25 REF.Serial Issue

INTERINDIVIDUELLE UNTERSCHIEDE DER PHARMAKOKINETIK BEIM MENSCHEN. KLINISCHE BEDEUTUNG = LES DIFFERENCES INTERINDIVIDUELLES DE LA PHARMACOCINETIQUE CHEZ L'HOMME. LA VALEUR CLINIQUESJOEQVIST F.1972; MUENCH. MED. WSCHR.; DTSCH.; DA. 1972; VOL. 114; NO 38; PP. 1600-1608; ABS. ANGL.; BIBL. 1P.Serial Issue

RESIDUAL MARROW DAMAGE: POSSIBLE EXPLANATION FOR IDIOSYNCRASY TO CHLORAMPHENICOL = LESION RESIDUELLE DE LA MOELLE OSSEUSE: EXPLICATION POSSIBLE DE L'IDIOSYNCRASIE AU CHLORAMPHENICOLMORLEY A; TRAINOR K; REMES J et al.1976; BRIT. J. HAEMATOL.; G.B.; DA. 1976; VOL. 32; NO 4; PP. 525-531; BIBL. 17 REF.Article

INDIVIDUALIZATION OF ANTICONVULSANT THERAPY = INDIVIDUALISATION DU TRAITEMENT ANTICONVULSIVANTATKINSON AJ JR.1974; MED. CLIN. N. AMER.; U.S.A.; DA. 1974; VOL. 58; NO 5; PP. 1037-1049; BIBL. 52REF.Article

DIFFERENZE INTERINDIVIDUALI NELLA FARMACOCINETICA NELL'UOMO: IMPORTANZA CLINICA = DIFFERENCES INDIVIDUELLES DANS LA PHARMACOCINETIQUE CHEZ L'HOMME: IMPORTANCE CLINIQUESJOEQVIST F.1973; MINERVA MED.; ITAL.; DA. 1973; VOL. 64; NO 17; PP. 866-879; BIBL. 1P.1/2Serial Issue

INDIVIDUALIZATION OF TREATMENT OF HYPERLIPOPROTEINEMIC DISORDERS = INDIVIDUALISATION DU TRAITEMENT DES TROUBLES HYPERLIPOPROTEINEMIQUESAZARNOFF DL.1974; MED. CLIN. N. AMER.; U.S.A.; DA. 1974; VOL. 58; NO 5; PP. 1129-1135; BIBL. 24REF.Article

BEHAVIORAL EFFECTS OF OPIATES: A PHARMACOGENETIC ANALYSISOLIVERIO A; CASTELLANO C.1981; CURR. DEV. PSYCHOPHARMACOL.; ISSN 0097-8361; USA; DA. 1981; VOL. 6; PP. 45-64; BIBL. 4 P.Article

CHIMIOTHERAPIE ET CHIMIOPROPHYLAXIE DE LA TUBERCULOSE CHEZ DES ENFANTS INTERNES DANS UN SANATORIUMKALABUKHA VA.1975; PROBL. TUBERK.; S.S.S.R.; DA. 1975; NO 10; PP. 7-11; ABS. ANGL.; BIBL. 1/2 P.Article

UNTERSUCHUNGEN UEBER DIE MEDIKAMENTEN-SERUMSPIEGEL ANTIKONVULSIV BEHANDELTER KINDER. I. ALLGEMEINE AUSWERTUNG DER SERUMKONZENTRATIONEN VON DIPHENYLHYDANTOIN, PRIMIDON UND PHENOBARBITAL = LES ETUDES SUR LES TAUX SERIQUES DES MEDICAMENTS CHEZ LES ENFANTS TRAITES PAR LES ANTICONVULSIVANTS. I. ETUDE GENERALE DES TAUX SERIQUES DE LA DIPHENYLHYDANTOINE, DU PRIMIDON ET DU PHENOBARBITALWINDORFER A JR; GAEDEKE R; SAUER M et al.1975; Z. KINDERHEILKDE; DTSCH.; DA. 1975; VOL. 119; NO 1; PP. 15-24; ABS. ANGL.; BIBL. 20REF.Article

INDIVIDUALIZATION OF TREATMENT WITH TRICYCLIC COMPOUNDS = INDIVIDUALISATION DU TRAITEMENT PAR LES COMPOSES TRICYCLIQUESASBERG M.1974; MED. CLIN. N. AMER.; U.S.A.; DA. 1974; VOL. 58; NO 5; PP. 1083-1091; BIBL. 2P.1/2Article

INDIVIDUAL DIFFERENCES IN EFFECTS OF TRICYCLIC ANTIDEPRESSANTS AND ANTOCHOLINERGIC DRUGS ON OPERANT BEHAVIOR IN THE SQUIRREL MONKEYMCKEARNEY JW.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 28; NO 18; PP. 2049-2054; BIBL. 14 REF.Article

INDIVIDUAL VARIATION IN THE RESPONSE TO PHENPROCOUMON.HUSTED S; ANDREASEN F.1977; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1977; VOL. 11; NO 5; PP. 351-358; BIBL. 26 REF.Article

DISPOSITION KINETICS OF QUINIDINEUEDA CT; HIRSCHFELD DS; SCHEINMAN MM et al.1976; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1976; VOL. 19; NO 1; PP. 30-36; BIBL. 27 REF.Article

ON THE ABSORPTION AND METABOLISM OF ³⁵S-AMPICILLIN.SWAHN A.1975; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1975; VOL. 9; NO 2-3; PP. 117-124; BIBL. 1 P.Article

DISTINCTIVE PATTERNS OF AMOBARBITAL METABOLITESKALOW W; TANG BK; KADAR D et al.1978; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1978; VOL. 24; NO 5; PP. 576-582; BIBL. 12 REF.Article

DIFFERENTIAL ANTIANGINAL RESPONSIVENESS TO ACEBUTOLOL = LA REPONSE ANTIANGINEUSE DIFFERENTIELLE A L'ACEBUTOLOLBIRON P; TREMBLAY G.1975; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1975; VOL. 8; NO 1; PP. 15-19; BIBL. 5REF.Article

INDIVIDUALIZATION OF PROPRANOLOL THERAPY = INDIVIDUALISATION DU TRAITEMENT PAR LE PROPRANOLOLSHAND DG.1974; MED. CLIN. N. AMER.; U.S.A.; DA. 1974; VOL. 58; NO 5; PP. 1063-1069; BIBL. 27REF.Article

VARIATIONS OF HEPARIN THERAPY FOR THROMBOEMBOLIC DISEASE = VARIATIONS DU TRAITEMENT PAR L'HEPARINE POUR MALADIE THROMBOEMBOLIQUEMARDER VJ.1974; MED. CLIN. N. AMER.; U.S.A.; DA. 1974; VOL. 58; NO 5; PP. 1121-1128; BIBL. 24REF.Article

THE EFFECTS OF ETHANOL (0.75 G/KG BODY WEIGHT) ON THE ACTIVITIES OF SELECTED ENZYMES IN SERA OF HEALTHY YOUNG ADULTS: I. INTERMEDIATE-TERM EFFECTS.FREER DE; STATLAND BE.1977; CLIN. CHEM.; U.S.A.; DA. 1977; VOL. 23; NO 5; PP. 830-834; BIBL. 12 REF.Article

CONTROL OF WARFARIN THERAPY IN THE ELDERLY.ECCLES JT.1975; AGE AND AGEING; G.B.; DA. 1975; VOL. 4; NO 3; PP. 161-165; BIBL. 17 REF.Article